Horizon Pharma
General
Total Cases150
Active Cases8
Patents110
Ratings
Experience
Grade
Trend
DCT
L4
E
PTAB
L5
E
CAFC
L4
D
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 05/17/24 | STIPULATION AND ORDER TO AMEND AND SUPPLEMENT THE DISCOVERY CONFIDENTIALITY ORDER. Signed by Magistrate Judge Ann Marie Donio on 5/17/2024. (sms2) (Entered: 05/17/2024) | |
| 05/17/24 | STIPULATION AND ORDER TO AMEND AND SUPPLEMENT THE DISCOVERY CONFIDENTIALITY ORDER. Signed by Magistrate Judge Ann Marie Donio on 5/17/2024. (sms2) (Entered: 05/17/2024) | |
| 05/10/24 | Letter from Charles H. Chevalier to the Honorable Ann Marie Donio, U.S.M.J.. (Attachments: # 1 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 05/10/2024) | |
| 05/10/24 | Letter from Charles H. Chevalier to the Honorable Ann Marie Donio, U.S.M.J.. (Attachments: # 1 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 05/10/2024) | |
| 04/10/24 | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) (Entered: 04/10/2024) | |
| 04/05/24 | Pro Hac Vice Fee - Credit Card Payment received for Christine Ranney, Josh Krevitt, Wayne Barsky, and Andrew Blythe. ( re 8 MOTION for Pro Hac Vice Appearance of Attorney )( Payment of $ 200, receipt number ADEDC-4378803).(Sharp, Melanie) (Entered: 04/05/2024) | |
| 04/05/24 | MOTION for Pro Hac Vice Appearance of Attorneys Christine Ranney, Esq., Josh Krevitt, Esq., Wayne Barsky, Esq., and Andrew Blythe, Esq. - filed by Horizon Therapeutics U.S. Holding LLC, Horizon Therapeutics USA, Inc.(oam) (Entered: 04/05/2024) | |
| 04/05/24 | Summons Issued as to Teva Pharmaceuticals, Inc. on 4/5/2024. (oam) (Entered: 04/05/2024) | |
| 04/05/24 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amgen Inc. for Horizon Therapeutics USA, Inc. filed by Horizon Therapeutics USA, Inc.. (oam) (Entered: 04/05/2024) | |
| 04/05/24 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Horizon Therapeutics USA, Inc. for Horizon Therapeutics U.S. Holding LLC filed by Horizon Therapeutics U.S. Holding LLC. (oam) (Entered: 04/05/2024) |